Search results
Author(s):
Tonje A Aksnes
,
Markus P Schneider
,
Sverre E Kjeldsen
,
et al
Added:
3 years ago
The renin–angiotensin system (RAS) has an important role in many cardiovascular diseases, such as hypertension, left ventricular hypertrophy, atherosclerosis and heart failure, and lately its relationship with cardiac arrhythmias has also been investigated.1 Atrial fibrillation is the most frequently occurring sustained cardiac arrhythmia and its prevalence doubles with each advancing decade of…
View more
Author(s):
Cheng Keat Tan
,
David Bin-Chia Wu
,
Seh Yi Joseph Tan
,
et al
Added:
5 months ago
Author(s):
Domenic A Sica
Added:
3 years ago
Introduction
Diabetes mellitus is rapidly increasing in its worldwide prevalence and is currently estimated to affect 7-8% of the US population.1 In 2005, 1.5 million new cases of diabetes were diagnosed in people aged 20 years or older in the US. In the not-so- distant past, type-2 diabetes mellitus was viewed as a seemingly benign condition, at least in the elderly, with little effect on life…
View more
Author(s):
Robert J Petrella
Added:
3 years ago
Hypertension is a chronic condition and a leading risk factor for the development of cardiovascular (CV) events, which are a major cause of morbidity and mortality worldwide.1–4 CV events create a significant clinical management and economic burden, and are a major cause of hospitalisation and physician visits.5 The burden associated with CV events may be alleviated by treating hypertension,…
View more
A Review of Angiotensin Receptor Blocker-based Therapies at all Levels of Cardiovascular Risk
Author(s):
Giuliano Tocci
,
Lorenzo Castello
,
Massimo Volpe
Added:
3 years ago
Article
Author(s):
Eliecer Coto
,
Pablo Avanzas
,
Juan Gómez
Added:
3 years ago
Author(s):
Roland Asmar
Added:
3 years ago
The greatest burden of cardiovascular disease (CVD) is due to non-fatal morbidity and its consequences; whereas CVD accounts for approximately 17 million deaths each year worldwide, current estimates indicate that CVD associated with asymptomatic disease and target organ damage as a result of undetected cardiovascular risk factors affects 128 million people worldwide.1,2 Moreover, the worldwide…
View more
Author(s):
Gurushankar Govindarajan
,
James R Sowers
,
Craig S Stump
Added:
3 years ago
There has been an increase in the prevalence of diabetes mellitus over the past 40 years, both in the US and worldwide. The worldwide prevalence of diabetes in 2000 was approximately 2.8% and is estimated to grow to 4.4% by 2030. This translates to a projected rise of diabetes from 171 million in 2000 to well over 350 million in 2030. The epidemic of diabetes will continue to rise as there is…
View more
Author(s):
Luis M Ruilope
Added:
3 years ago
Globally, an estimated 26.4% of the adult population suffers from hypertension, and this figure is set to rise by 3% by 2025.1 The condition is asymptomatic and is often dubbed the ‘silent killer’ because it frequently goes undetected. The clinical significance of hypertension stems from the increased risk of end organ damage due to elevated blood pressure (BP) (see Figure 1). Chronic high BP is…
View more
Author(s):
Christoph Maack
,
Michael Böhm
Added:
3 years ago
Chronic heart failure is the leading cause of hospitalisation in Germany1 and other European countries. It is the result of various cardiovascular diseases, such as myocardial infarction, arterial hypertension and valvular heart diseases. About 50 % of patients with heart failure have normal systolic, but impaired diastolic function, a condition termed heart failure with preserved ejection…
View more